Skip to main content

Advertisement

Table 1 Summary data for retinitis pigmentosa patients and the retinal progenitor cells

From: Long-term safety of human retinal progenitor cell transplantation in retinitis pigmentosa patients

    BCVA (logMAR) Donor cells
Patients Age (years) Sex OS OD Gestational age (weeks) Viability
1 42 M 1.56 1.6 14 >98%
2 33 F 1.30 1.3 15 >98%
3 34 M 1.00 0.8 12 90–93%
4 19 M 0.35 0.3 12 95%
5 46 F 1.52 0.9 15 96%
6 19 F 1.30 0.4 12 94%
7 53 F 2.00 1.8 12 95%
8 38 F 0.92 1.0 12 93%
  1. BCVA best corrected visual acuity, F female, M, male, MAR minimum angle of resolution, OD right eye without treatment, OS left eye with transplant